webleads-tracker

Pharma Compliance Info EFPIA | Securing the basis for collaboration in the future EFPIA

EFPIA | Securing the basis for collaboration in the future

Later this month we will be at the European Cancer Congress 2015 talking about why, from early 2016, the pharmaceutical industry in Europe will begin disclosing payments made to health professionals for activities. They include consultancy, attending advisory boards, speaking at educational meetings, travel, accommodation and registration for congresses etc.
As well as speaking at a plenary session, we will be hosting a stand where anyone can come and see us, find out more, and ask any questions they might have. With a myriad of delegates from all over Europe, we are looking forward to some lively discussion and debate. No doubt many will want to know the rationale behind this significant step, why now and what form will the disclosures take?
Collaboration between industry and health professionals benefits patients. It is a relationship that has delivered numerous innovative medicines and changed the way many diseases impact on our lives. They collaborate in a range of activities, from clinical research to sharing best clinical practice and exchanging information on how new medicines fit into the patient pathway.
Bringing greater transparency to this, already well-regulated, vital relationship is essential to strengthen the basis for collaboration in the future.

To read the article by Andrew Powrie-Smith

Check Also

Pharma Compliance Info Belgique | Arrêté royal portant exécution du Sunshine Act EFPIA

Belgique | Arrêté royal portant exécution du Sunshine Act

PHILIPPE, Roi des Belges, A tous, présents et à venir, Salut. Vu l’article 108 de …

X